Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03212742
Title Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients (OLA-TMZ-RTE-01)
Acronym OLA-TMZ-RTE-01
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHU RECRUITING Amiens France Details
Institut de Cancérologie de l'Ouest RECRUITING Angers France Details
CHU RECRUITING Bordeaux France Details
Centre François Baclesse RECRUITING Caen 14076 France Details
Centre Guillaume le Conquérant RECRUITING Le Havre France Details
CH du Havre RECRUITING Le Havre France Details
GHBS NOT_YET_RECRUITING Lorient France Details
Centre léon Bérard RECRUITING Lyon France Details
Hôpitaux universitaires La Pitié Salpétrière - Charles Foix RECRUITING Paris France Details
Institut Curie NOT_YET_RECRUITING Paris France Details
Centre Hospitalier Lyon Sud NOT_YET_RECRUITING Pierre-Bénite France Details
Centre Eugène Marquis NOT_YET_RECRUITING Rennes France Details
Centre Henri Becquerel RECRUITING Rouen France Details
Institut de Cancérologie de l'Ouest RECRUITING Saint-Herblain France Details
Institut Claudius Regaud RECRUITING Toulouse France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field